Fryer Madeline L, Palleiko Benjamin A, Emmerick Isabel, Crawford Allison, Kadiyala Mamatha, Lou Feiran, Uy Karl, Maxfield Mark W
Department of Surgery, UMass Chan Medical School, Worcester, MA, USA.
Department of Anesthesiology, UMass Chan Medical School, Worcester, MA, USA.
J Thorac Dis. 2024 Feb 29;16(2):1324-1337. doi: 10.21037/jtd-23-1500. Epub 2024 Feb 26.
Enhanced recovery after surgery (ERAS) protocols in thoracic surgery have been demonstrated to impact length of stay (LOS), complication rates, and postoperative opioid use. However, ERAS protocols for minimally invasive lung resections have not been well described. Given most lung resections are now performed minimally invasively, there is a gap in the literature regarding the efficacy of ERAS protocols in this setting. In this study, we analyzed patient outcomes following implementation of an ERAS protocol for minimally invasive lung resections.
Outcome data was retrospectively collected for 442 patients undergoing minimally invasive lung resections between January 1, 2015 and October 26, 2021. Patients were divided into either a pre-ERAS (n=193) or ERAS (n=249) group. Primary outcomes included LOS, postoperative complications, intensive care unit (ICU) admission status, 30-day hospital readmissions, and 30-day mortality. Secondary outcomes included common postoperative complications required for the Society for Thoracic Surgeons (STS) database.
We observed an overall decrease in median LOS (4.0 3.0 days, P=0.030) and ICU admission status (15% 7.6%, P=0.020) after implementation of our ERAS protocol. The difference in LOS was significantly lower for anatomic lung resections, but not non-anatomic resections. There was no difference in 30-day readmissions and a 0% mortality rate in both groups. Overall, there was a low complication rate that was similar between groups.
The implementation of an ERAS protocol led to decreased LOS and decreased ICU admission in patients undergoing minimally invasive lung resection. Process standardization optimizes performance by providers by decreasing decision fatigue and improving decision making, which may contribute to the improved outcomes observed in this study.
胸外科手术的加速康复(ERAS)方案已被证明会影响住院时间(LOS)、并发症发生率和术后阿片类药物的使用。然而,关于微创肺切除的ERAS方案尚未得到充分描述。鉴于目前大多数肺切除术都是通过微创方式进行的,关于ERAS方案在这种情况下的疗效,文献中存在空白。在本研究中,我们分析了实施微创肺切除ERAS方案后的患者结局。
回顾性收集了2015年1月1日至2021年10月26日期间442例行微创肺切除患者的结局数据。患者分为ERAS前组(n = 193)和ERAS组(n = 249)。主要结局包括住院时间、术后并发症、重症监护病房(ICU)入住情况、30天内再次入院情况和30天死亡率。次要结局包括胸外科医师协会(STS)数据库所需的常见术后并发症。
实施我们的ERAS方案后,我们观察到中位住院时间总体下降(4.0对3.0天,P = 0.030),ICU入住情况下降(15%对7.6%,P = 0.020)。解剖性肺切除的住院时间差异显著更低,但非解剖性切除则不然。两组的30天再次入院率无差异,死亡率均为0%。总体而言,并发症发生率较低,两组相似。
ERAS方案的实施导致接受微创肺切除患者的住院时间缩短和ICU入住率降低。流程标准化通过减少决策疲劳和改善决策来优化医疗服务提供者的表现,这可能有助于本研究中观察到的结局改善。